DuPont announced that Arclin, a portfolio company of an affiliate of TJC, L.P., has reached a definitive agreement to acquire DuPont’s Aramids business, which includes Kevlar and Nomex. The transaction values the business at approximately $1.8 billion and is expected to close in the first quarter of 2026, subject to customary conditions and regulatory approval.

At close, DuPont will receive pre-tax cash proceeds of approximately $1.2 billion, a $300 million note receivable, and a non-controlling equity interest in the future Arclin company currently valued at $325 million, representing an estimated 17.5% stake.

“This announcement is another important step in our continued optimization of the new DuPont portfolio,” said Lori Koch, DuPont chief executive officer. “The Aramids transaction further enhances the strategic focus of our portfolio while also increasing the growth and margin profile.”

Bradley Bolduc, Arclin’s president and CEO, said the addition of Kevlar and Nomex “presents a unique opportunity to transform our business with increased scale, broader global reach, and market-leading application development capabilities.”

The Aramids business is the inventor and largest global producer of high-performance synthetic fibers, known for protecting people, equipment, and structures in high-cost-of-failure applications. With about 1,900 employees and five manufacturing sites, the business generated net sales of $1.3 billion in 2024.

This acquisition highlights continuing portfolio restructuring trends in the coatings and advanced materials industry. Learn more about mergers and acquisitions.